Quarterly report pursuant to Section 13 or 15(d)

Inventory (Tables)

Inventory (Tables)
3 Months Ended
Mar. 31, 2021
Inventory Disclosure [Abstract]  
Schedule of inventories
Inventories are comprised of unprocessed tissue, work-in-process, Avance® Nerve Graft, Axoguard® Nerve Connector, Axoguard® Nerve Protector, Axoguard® Nerve Cap, Avive® Soft Tissue Membrane, Acroval® Neurosensory and Motor Testing System, Axotouch® Two-Point Discriminator and supplies and are valued at the lower of cost (first-in, first-out) or net realizable value and consist of the following:
March 31,
December 31,
Finished goods $ 9,309  $ 8,876 
Work in process 782  751 
Raw materials 3,297  2,902 
Inventories $ 13,388  $ 12,529